Cell and Gene Therapy Manufacturing QC-Global Market Status and Trend Report 2016-2026

Table of Contents

Chapter 1 Overview of Cell and Gene Therapy Manufacturing QC

• 1.1 Definition of Cell and Gene Therapy Manufacturing QC in This Report
• 1.2 Commercial Types of Cell and Gene Therapy Manufacturing QC
  • 1.2.1 Safety Testing
  • 1.2.2 Purity Testing
  • 1.2.3 Potency Testing
  • 1.2.4 Identity Testing
  • 1.2.5 Stability Testing
• 1.3 Downstream Application of Cell and Gene Therapy Manufacturing QC
  • 1.3.1 Precision Therapy
  • 1.3.2 Biological Research
• 1.4 Development History of Cell and Gene Therapy Manufacturing QC
• 1.5 Market Status and Trend of Cell and Gene Therapy Manufacturing QC 2016-2026
  • 1.5.1 Global Cell and Gene Therapy Manufacturing QC Market Status and Trend 2016-2026
  • 1.5.2 Regional Cell and Gene Therapy Manufacturing QC Market Status and Trend 2016-2026

Chapter 2 Global Market Status and Forecast by Regions

• 2.1 Market Development of Cell and Gene Therapy Manufacturing QC 2016-2021
• 2.2 Production Market of Cell and Gene Therapy Manufacturing QC by Regions
  • 2.2.1 Production Volume of Cell and Gene Therapy Manufacturing QC by Regions
  • 2.2.2 Production Value of Cell and Gene Therapy Manufacturing QC by Regions
• 2.3 Demand Market of Cell and Gene Therapy Manufacturing QC by Regions
• 2.4 Production and Demand Status of Cell and Gene Therapy Manufacturing QC by Regions
  • 2.4.1 Production and Demand Status of Cell and Gene Therapy Manufacturing QC by Regions 2016-2021
  • 2.4.2 Import and Export Status of Cell and Gene Therapy Manufacturing QC by Regions 2016-2021

Chapter 3 Global Market Status and Forecast by Types

• 3.1 Production Volume of Cell and Gene Therapy Manufacturing QC by Types
• 3.2 Production Value of Cell and Gene Therapy Manufacturing QC by Types
• 3.3 Market Forecast of Cell and Gene Therapy Manufacturing QC by Types

Chapter 4 Global Market Status and Forecast by Downstream Industry

• 4.1 Demand Volume of Cell and Gene Therapy Manufacturing QC by Downstream Industry
• 4.2 Market Forecast of Cell and Gene Therapy Manufacturing QC by Downstream Industry

Chapter 5 Market Driving Factor Analysis of Cell and Gene Therapy Manufacturing QC

• 5.1 Global Economy Situation and Trend Overview
• 5.2 Cell and Gene Therapy Manufacturing QC Downstream Industry Situation and Trend Overview

Chapter 6 Cell and Gene Therapy Manufacturing QC Market Competition Status by Major Manufacturers

• 6.1 Production Volume of Cell and Gene Therapy Manufacturing QC by Major Manufacturers
• 6.2 Production Value of Cell and Gene Therapy Manufacturing QC by Major Manufacturers
• 6.3 Basic Information of Cell and Gene Therapy Manufacturing QC by Major Manufacturers
  • 6.3.1 Headquarters Location and Established Time of Cell and Gene Therapy Manufacturing QC Major Manufacturer
  • 6.3.2 Employees and Revenue Level of Cell and Gene Therapy Manufacturing QC Major Manufacturer
• 6.4 Market Competition News and Trend
  • 6.4.1 Merger, Consolidation or Acquisition News
  • 6.4.2 Investment or Disinvestment News
  • 6.4.3 New Product Development and Launch

Chapter 7 Cell and Gene Therapy Manufacturing QC Major Manufacturers Introduction and Market Data

• 7.1 Bio-Techne Corporation
  • 7.1.1 Company profile
  • 7.1.2 Representative Cell and Gene Therapy Manufacturing QC Product
  • 7.1.3 Cell and Gene Therapy Manufacturing QC Sales, Revenue, Price and Gross Margin of Bio-Techne Corporation
• 7.2 BioMerieux SA
  • 7.2.1 Company profile
  • 7.2.2 Representative Cell and Gene Therapy Manufacturing QC Product
  • 7.2.3 Cell and Gene Therapy Manufacturing QC Sales, Revenue, Price and Gross Margin of BioMerieux SA
• 7.3 Catalent, Inc.
  • 7.3.1 Company profile
  • 7.3.2 Representative Cell and Gene Therapy Manufacturing QC Product
  • 7.3.3 Cell and Gene Therapy Manufacturing QC Sales, Revenue, Price and Gross Margin of Catalent, Inc.
• 7.4 Charles River Laboratories International Inc.
  • 7.4.1 Company profile
  • 7.4.2 Representative Cell and Gene Therapy Manufacturing QC Product
  • 7.4.3 Cell and Gene Therapy Manufacturing QC Sales, Revenue, Price and Gross Margin of Charles River Laboratories International Inc.
• 7.5 Eurofins Scientific SE
  • 7.5.1 Company profile
  • 7.5.2 Representative Cell and Gene Therapy Manufacturing QC Product
  • 7.5.3 Cell and Gene Therapy Manufacturing QC Sales, Revenue, Price and Gross Margin of Eurofins Scientific SE
• 7.6 F. Hoffmann-La Roche Ltd
  • 7.6.1 Company profile
  • 7.6.2 Representative Cell and Gene Therapy Manufacturing QC Product
  • 7.6.3 Cell and Gene Therapy Manufacturing QC Sales, Revenue, Price and Gross Margin of F. Hoffmann-La Roche Ltd
• 7.7 Intertek Group plc
  • 7.7.1 Company profile
  • 7.7.2 Representative Cell and Gene Therapy Manufacturing QC Product
  • 7.7.3 Cell and Gene Therapy Manufacturing QC Sales, Revenue, Price and Gross Margin of Intertek Group plc
• 7.8 Lonza Group AG
  • 7.8.1 Company profile
  • 7.8.2 Representative Cell and Gene Therapy Manufacturing QC Product
  • 7.8.3 Cell and Gene Therapy Manufacturing QC Sales, Revenue, Price and Gross Margin of Lonza Group AG
• 7.9 Merck KGaA
  • 7.9.1 Company profile
  • 7.9.2 Representative Cell and Gene Therapy Manufacturing QC Product
  • 7.9.3 Cell and Gene Therapy Manufacturing QC Sales, Revenue, Price and Gross Margin of Merck KGaA
• 7.10 Sartorius AG
  • 7.10.1 Company profile
  • 7.10.2 Representative Cell and Gene Therapy Manufacturing QC Product
  • 7.10.3 Cell and Gene Therapy Manufacturing QC Sales, Revenue, Price and Gross Margin of Sartorius AG
• 7.11 SGS S.A.
  • 7.11.1 Company profile
  • 7.11.2 Representative Cell and Gene Therapy Manufacturing QC Product
  • 7.11.3 Cell and Gene Therapy Manufacturing QC Sales, Revenue, Price and Gross Margin of SGS S.A.
• 7.12 Sistemic Scotland Limited
  • 7.12.1 Company profile
  • 7.12.2 Representative Cell and Gene Therapy Manufacturing QC Product
  • 7.12.3 Cell and Gene Therapy Manufacturing QC Sales, Revenue, Price and Gross Margin of Sistemic Scotland Limited
• 7.13 Thermo Fisher Scientific Inc.
  • 7.13.1 Company profile
  • 7.13.2 Representative Cell and Gene Therapy Manufacturing QC Product
  • 7.13.3 Cell and Gene Therapy Manufacturing QC Sales, Revenue, Price and Gross Margin of Thermo Fisher Scientific Inc.
• 7.14 Vigene Biosciences, Inc.
  • 7.14.1 Company profile
  • 7.14.2 Representative Cell and Gene Therapy Manufacturing QC Product
  • 7.14.3 Cell and Gene Therapy Manufacturing QC Sales, Revenue, Price and Gross Margin of Vigene Biosciences, Inc.
• 7.15 WuXi AppTec
  • 7.15.1 Company profile
  • 7.15.2 Representative Cell and Gene Therapy Manufacturing QC Product
  • 7.15.3 Cell and Gene Therapy Manufacturing QC Sales, Revenue, Price and Gross Margin of WuXi AppTec

Chapter 8 Upstream and Downstream Market Analysis of Cell and Gene Therapy Manufacturing QC

• 8.1 Industry Chain of Cell and Gene Therapy Manufacturing QC
• 8.2 Upstream Market and Representative Companies Analysis
• 8.3 Downstream Market and Representative Companies Analysis

Chapter 9 Cost and Gross Margin Analysis of Cell and Gene Therapy Manufacturing QC

• 9.1 Cost Structure Analysis of Cell and Gene Therapy Manufacturing QC
• 9.2 Raw Materials Cost Analysis of Cell and Gene Therapy Manufacturing QC
• 9.3 Labor Cost Analysis of Cell and Gene Therapy Manufacturing QC
• 9.4 Manufacturing Expenses Analysis of Cell and Gene Therapy Manufacturing QC

Chapter 10 Marketing Status Analysis of Cell and Gene Therapy Manufacturing QC

• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
  • 10.1.3 Marketing Channel Development Trend
• 10.2 Market Positioning
  • 10.2.1 Pricing Strategy
  • 10.2.2 Brand Strategy
  • 10.2.3 Target Client
• 10.3 Distributors/Traders List

Chapter 11 Report Conclusion

Chapter 12 Research Methodology and Reference

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources